Outcomes After Transcatheter Aortic Valve Replacement in Bicuspid Versus Tricuspid Anatomy-Reference-Cited by-同舟云学术

Outcomes After Transcatheter Aortic Valve Replacement in Bicuspid Versus Tricuspid Anatomy

Published:2021-10 Issue:19 Volume:14 Page:2144-2155
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Montalto Claudio,Sticchi Alessandro,Crimi Gabriele,Laricchia Alessandra,Khokhar Arif A.,Giannini Francesco,Reimers Bernhard,Colombo Antonio,Latib Azeem,Waksman Ron,Mangieri Antonio

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. Bicuspid aortic valve disease;Siu;J Am Coll Cardiol,2010

2. Bicuspid aortic valve identifying knowledge gaps and rising to the challenge from the International Bicuspid Aortic Valve Consortium (BAVCON);Michelena;Circulation,2014

3. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation;Roberts;Circulation,2005

4. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients;Mack;N Engl J Med,2019

5. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients;Popma;N Engl J Med,2019

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paravalvular Leak After Transcatheter Aortic Valve Implantation: Importance of Preprocedural Variables and Intraprocedural Assessment;Journal of the American Heart Association;2024-09-13

2. Comparison of downsizing strategy (HANGZHOU Solution) and standard annulus sizing strategy in type 0 bicuspid aortic stenosis patients undergoing transcatheter aortic valve replacement: Rationale and design of a randomized clinical trial;American Heart Journal;2024-08

3. Incidence, Predictors, and Outcomes of Paravalvular Regurgitation After TAVR in Sievers Type 1 Bicuspid Aortic Valves;JACC: Cardiovascular Interventions;2024-07

4. 3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study;JACC: Cardiovascular Interventions;2024-07

5. Assuring Success?;JACC: Cardiovascular Interventions;2024-07